These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21892091)

  • 1. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II of Radiation Therapy Oncology Group (RTOG) 0116.
    Small W; Winter K; Levenback C; Iyer R; Hymes SR; Jhingran A; Gaffney D; Erickson B; Greven K
    Int J Gynecol Cancer; 2011 Oct; 21(7):1266-75. PubMed ID: 21892091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116.
    Small W; Winter K; Levenback C; Iyer R; Gaffney D; Asbell S; Erickson B; Jhingran A; Greven K
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1081-7. PubMed ID: 17398031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoprotection/radioprotection with amifostine: potential role in cervical cancer and early findings in the Radiation Therapy Oncology Group C-0116 trial.
    Small W;
    Semin Oncol; 2003 Dec; 30(6 Suppl 18):68-71. PubMed ID: 14727243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
    Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential for use of amifostine in cervical cancer.
    Small W
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):34-7. PubMed ID: 12577241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
    Grigsby PW; Lu JD; Mutch DG; Kim RY; Eifel PJ
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):817-22. PubMed ID: 9652843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
    Sood BM; Gorla G; Gupta S; Garg M; Deore S; Runowicz CD; Fields AL; Goldberg GL; Anderson PS; Vikram B
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):702-6. PubMed ID: 12062615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.
    Rotman M; Pajak TF; Choi K; Clery M; Marcial V; Grigsby PW; Cooper J; John M
    JAMA; 1995 Aug; 274(5):387-93. PubMed ID: 7616634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is a low dose of concomitant chemotherapy with extended-field radiotherapy acceptable as an efficient treatment for cervical cancer patients with metastases to the para-aortic lymph nodes?
    Kazumoto T; Kato S; Yokota H; Hasumi Y; Kino N; Horie K; Yoshida D; Mizukami T; Saito Y
    Int J Gynecol Cancer; 2011 Nov; 21(8):1465-71. PubMed ID: 21892097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer.
    Antonadou D
    Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):50-8. PubMed ID: 11917285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
    Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-field intensity-modulated radiation therapy combined with concurrent chemotherapy for cervical cancer with para-aortic lymph nodes metastasis.
    Liu X; Wang W; Meng Q; Zhang F; Hu K
    Jpn J Clin Oncol; 2019 Mar; 49(3):263-269. PubMed ID: 30668725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
    Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
    N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
    Kim JS; Kim JS; Kim SY; Kim Ki; Cho MJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1247-53. PubMed ID: 12654434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential role of amifostine in conjunction with cisplatin in the treatment of locally advanced carcinoma of the cervix.
    Wadler S; Goldberg G; Fields A; Anderson P; Beitler JJ; Sood B; Haynes H; Runowicz C
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):64-8. PubMed ID: 8783670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of amifostine in the treatment of carcinoma of the uterine cervix: an update of RTOG-0116 and review of future directions.
    De Los Santos JF; Small W
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):37-41. PubMed ID: 15726521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
    Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer.
    Antonadou D; Petridis A; Synodinou M; Throuvalas N; Bolanos N; Veslemes M; Sagriotis A
    Semin Oncol; 2003 Dec; 30(6 Suppl 18):2-9. PubMed ID: 14727235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of elective para-aortic lymph node irradiation in patients with locally advanced cervical cancer.
    Yap ML; Cuartero J; Yan J; Pintilie M; Fyles A; Levin W; Manchul L; Milosevic M
    Clin Oncol (R Coll Radiol); 2014 Dec; 26(12):797-803. PubMed ID: 25194726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of extended-field irradiation and intracavitary brachytherapy combined with weekly cisplatin chemosensitization for IB2-IIIB cervical cancer with positive paraaortic or high common iliac lymph nodes: a retrospective review.
    Kuji S; Hirashima Y; Komeda S; Tanaka A; Abe M; Takahashi N; Takekuma M; Asakura H; Harada H; Nishimura T
    Int J Clin Oncol; 2014 Apr; 19(2):341-7. PubMed ID: 23546545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.